Paracetamol (acetaminophen) - A popular and widely used nonopioid analgesic

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 8, 2012, Pages 355-359

  Klotz, U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

acetaminophen; clinical safety; NSAID; pain management; paracetamol; pharmacological properties; therapeutic use

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADVERSE OUTCOME; ANALGESIA; ANALGESIC ACTIVITY; BRAIN; CARDIOVASCULAR DISEASE; CHRONIC PAIN; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; LIVER; PAIN; REVIEW;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; HUMANS;

EID: 84865631115     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0032-1321785     Document Type: Review

References (54)

1. Bertolini A, Ferrari A, Ottani A et al. Paracetamol: new vistas of an old drug. CNS Drug Rev: 2006; 12 250 275 (Pubitemid 46047791)
2. Nikles C J, Yelland M, Del M C et al. The role of paracetamol in chronic pain: an evidence-based approach. Am J Ther: 2005; 12 80 91 (Pubitemid 40516049)
3. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons Pharmacological management of persistent pain in older persons. J Am Geriatr Soc: 2009; 57 1331 1346
4. Guggenheimer J, Moore P A. The therapeutic applications of and risks associated with acetaminophen use: a review and update. J Am Dent Assoc: 2011; 142 38 44
5. Flood J. The role of acetaminophen in the treatment of osteoarthritis. Am J Manag Care: 2010; 16 (Suppl Management) S48 S54
6. Reid M C, Shengelia R, Parker S J. Pharmacologic management of osteoarthritis-related pain in older adults: a review shows that many drug therapies provide small-to-modest pain relief. Orthop Nurs: 2012; 31 109 114
7. Goldstein L H, Berlin M, Berkovitch M et al. Effectiveness of oral vs rectal acetaminophen: a meta-analysis. Arch Pediatr Adolesc Med: 2008; 162 1042 1046
8. Jahr J S, Lee V K. Intravenous acetaminophen. Anesthesiol Clin: 2010; 28 619 645
9. Jones V M. Acetaminophen injection: a review of clinical information. J Pain Palliat Care Pharmacother: 2011; 25 340 349
10. Purssell E. Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone. Arch Dis Child: 2011; 96 1175 1179
11. de Vries F, Setakis E, van Staa T P. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol: 2010; 70 429 438
12. Toms L, Derry S, Moore R A et al. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev: 2009; CD001547-
13. Dhillon S. Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain. Clin Drug Investig: 2010; 30 711 738
14. Sawaddiruk P. Tramadol hydrochloride/acetaminophen combination for the relief of acute pain. Drugs Today (Barc): 2011; 47 763 772
15. Forrest J A, Clements J A, Prescott L F. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet: 1982; 7 93 107 (Pubitemid 12070476)
16. Toussaint K, Yang X C, Zielinski M A et al. What do we (not) know about how paracetamol (acetaminophen) works? J Clin Pharm Ther: 2010; 35 617 638
17. van der Marel C D, Anderson B J, van Lingen R A et al. Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol: 2003; 59 243 251 (Pubitemid 36995133)
18. Mohammed B S, Engelhardt T, Cameron G A et al. Population pharmacokinetics of single-dose intravenous paracetamol in children. Br J Anaesth: 2012; 108 823 829
19. Liukas A, Kuusniemi K, Aantaa R et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet: 2011; 50 121 129
20. Shinoda S, Aoyama T, Aoyama Y et al. Pharmacokinetics/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain. Biol Pharm Bull: 2007; 30 157 161 (Pubitemid 46066337)
21. Bannwarth B, Pehourcq F. Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs: 2003; 63 Spec No 2 5 13 (Pubitemid 37311128)
22. Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev: 2011; 43 41 52
23. Gelotte C K, Auiler J F, Lynch J M et al. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther: 2007; 81 840 848 (Pubitemid 46788290)
24. McQuay H J, Moore R A. Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies. Br J Clin Pharmacol: 2007; 63 271 278
25. Pickering G, Loriot M A, Libert F et al. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther: 2006; 79 371 378
26. Pickering G, Esteve V, Loriot M A et al. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther: 2008; 84 47 51 (Pubitemid 351861483)
27. Hogestatt E D, Jonsson B A, Ermund A et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem: 2005; 280 31405 31412 (Pubitemid 41291881)
28. Andersson D A, Gentry C, Alenmyr L et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nat Commun: 2011; 2 551
29. Toms L, McQuay H J, Derry S et al. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev: 2008; CD004602-
30. Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis: 2002; 61 767 773
31. Oscier C D, Milner Q J. Peri-operative use of paracetamol. Anaesthesia: 2009; 64 65 72
32. Benson G D, Koff R S, Tolman K G. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther: 2005; 12 133 141 (Pubitemid 40516030)
33. Petersen K U. Paracetamol und die Leber. MMV Forschr Med: 2011; 153 137 142
34. Lavonas E J, Reynolds K M, Dart R C. Therapeutic acetaminophen is not associated with liver injury in children: a systematic review. Pediatrics: 2010; 126 e1430 e1444
35. Southey E R, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin: 2009; 25 2207 2222
36. Rumack B H, Bateman D N. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila): 2012; 50 91 98
37. Scialli A R, Ang R, Breitmeyer J et al. Childhood asthma and use during pregnancy of acetaminophen. A critical review. Reprod Toxicol: 2010; 30 508 519
38. Schnabel E, Heinrich J. Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood. J Allergy Clin Immunol: 2010; 126 1071 1073
39. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ: 2004; 328 434
40. Risser A, Donovan D, Heintzman J et al. NSAID prescribing precautions. Am Fam Physician: 2009; 80 1371 1378
41. Mattia A, Coluzzi F. What anesthesiologists should know about paracetamol (acetaminophen). Minerva Anestesiol: 2009; 75 644 653
42. Lavonas E J, Fries J F, Furst D E et al. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf: 2012; 11 33 44
43. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med: 2011; 8 e1001098
44. Lanas A, Garcia-Tell G, Armada B et al. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med: 2011; 9 38
45. Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf: 2009; 8 669 681
46. Bavry A A, Khaliq A, Gong Y et al. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med: 2011; 124 614 620
47. Merrill G F, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol: 2001; 96 423 430 (Pubitemid 34071091)
48. Leshnower B G, Sakamoto H, Zeeshan A et al. Role of acetaminophen in acute myocardial infarction. Am J Physiol Heart Circ Physiol: 2006; 290 H2424 H2431 (Pubitemid 43846071)
49. Langman M J, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet: 1994; 343 1075 1078
50. Henry D, Lim L L, Garcia Rodriguez L A et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ: 1996; 312 1563 1566 (Pubitemid 26188573)
51. Laine L, Smith R, Min K et al. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther: 2006; 24 751 767
52. Lanas A. A review of the gastrointestinal safety data - a gastroenterologist's perspective. Rheumatology (Oxford): 2010; 49 02 ii3 ii10
53. Fine P G. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med: 2012; 13 02 S57 S66
54. Sarzi-Puttini P, Vellucci R, Zuccaro S M et al. The appropriate treatment of chronic pain. Clin Drug Investig: 2012; 32 01 21 33